Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Huarte

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Letters|June 9, 2009
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanomaEduardo Huarte, Jan Fisher, Mary Jo Turk, et al.
Immunotherapy|June 29, 2021
Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse modelsEduardo Huarte, Michael Peel, Ashish Juvekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsEduardo Huarte, Pablo Sarobe, Jun Lu, et al.
Oncoimmunology|February 6, 2014
Helper cell-independent antitumor activity of potent CD8<sup>+</sup> T cell epitope peptide vaccines is dependent upon CD40LDiana Llopiz, Eduardo Huarte, Marta Ruiz, et al.
Expert Opinion on Biological Therapy|February 16, 2005
Intratumoural administration of dendritic cells: hostile environment and help by gene therapyEduardo Huarte, Iñigo Tirapu, Ainhoa Arina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigenHiroya Kobayashi, Ryusuke Omiya, Marta Ruiz, et al.
Journal of Autoimmunity|October 25, 2011
Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAEEduardo Huarte, Agnieszka Rynda-Apple, Carol Riccardi, et al.
Cancer Immunity|December 17, 2004
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clonesEduardo Huarte, Julia Karbach, Sacha Gnjatic, et al.
Cancer Research|February 21, 2006
Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinomaIñigo Tirapu, Eduardo Huarte, Cristiana Guiducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell TherapyEduardo Huarte, Roddy S O'Connor, Michael T Peel, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Letters|June 9, 2009
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanomaEduardo Huarte, Jan Fisher, Mary Jo Turk, et al.
Immunotherapy|June 29, 2021
Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse modelsEduardo Huarte, Michael Peel, Ashish Juvekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsEduardo Huarte, Pablo Sarobe, Jun Lu, et al.
Oncoimmunology|February 6, 2014
Helper cell-independent antitumor activity of potent CD8<sup>+</sup> T cell epitope peptide vaccines is dependent upon CD40LDiana Llopiz, Eduardo Huarte, Marta Ruiz, et al.
Expert Opinion on Biological Therapy|February 16, 2005
Intratumoural administration of dendritic cells: hostile environment and help by gene therapyEduardo Huarte, Iñigo Tirapu, Ainhoa Arina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigenHiroya Kobayashi, Ryusuke Omiya, Marta Ruiz, et al.
Journal of Autoimmunity|October 25, 2011
Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAEEduardo Huarte, Agnieszka Rynda-Apple, Carol Riccardi, et al.
Cancer Immunity|December 17, 2004
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clonesEduardo Huarte, Julia Karbach, Sacha Gnjatic, et al.
Cancer Research|February 21, 2006
Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinomaIñigo Tirapu, Eduardo Huarte, Cristiana Guiducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell TherapyEduardo Huarte, Roddy S O'Connor, Michael T Peel, et al.
Pageof 3